Hamilton, Ontario
Transformative made-in-Canada health solutions are crucial to improving the healthcare of Canadians. To support these efforts, the Government of Canada is making strategic investments to foster collaboration and drive innovation and growth in this sector.
Today, the Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), visited with members of McMaster University's Global Nexus, a partnership-focused health innovation accelerator, to announce a FedDev Ontario investment of $4 million towards the new Centre for Collaborative Chemistry (C3).
During the visit, Minister Tassi learned about the University's plans for C3 and how the Government of Canada's support will increase the adoption of advanced equipment to fast-track Canadian drug discovery. Once operational, C3 will provide an environment to accelerate the development and commercialization of pharmaceutical products.
With this investment, C3 will also leverage the regional life sciences ecosystem to provide small- and medium-sized enterprises (SMEs) with access to highly qualified personnel as well as training, mentorship and collaboration opportunities to develop and commercialize meaningful and effective healthcare solutions.
The Government of Canada is committed to fostering innovation in the life sciences sector by equipping Canadian businesses, organizations and academia with the necessary tools to innovate, grow, improve the lives of Canadians, and to compete on the global stage.
